TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)
$38.78 -1.51 (-3.7478%)
Analysed TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) News Sources
Travere Therapeutics Director Trims Stake Amid 168% Run, But Is FILSPARI's Revenue Story Just Getting Started?
20-04-2026
fool.com
Travere Therapeutics (TVTX) Climbs 40.8% on Filspari Approval
20-04-2026
yahoo.com
Here is Why Travere (TVTX) is an Overlooked Growth Stocks to Buy Now
19-04-2026
yahoo.com
Four Biotech Stocks Near Buy Points As Earnings Season Kicks In
17-04-2026
yahoo.com
Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?
17-04-2026
yahoo.com
How The Travere Therapeutics (TVTX) Story Is Shifting After FSGS Approval And Split Analyst Views
16-04-2026
yahoo.com
A Look At Travere Therapeutics (TVTX) Valuation After FILSPARI’s Landmark FDA Approval For FSGS
16-04-2026
yahoo.com
TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication
15-04-2026
yahoo.com
Travere (TVTX) Soars 37.2%: Is Further Upside Left in the Stock?
15-04-2026
yahoo.com
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14-04-2026
yahoo.com
What is the current price of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?
The current price of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is $38.78.
TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) since the previous trading day is $-1.51.
TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) since the previous trading day is -3.7478%.
What is the most recent average sentiment score for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?
The most recent average sentiment score for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?
The most recent sentiment for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is .
SEC-8K** Filing Available For TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.